Sight Sciences Announces First Patients Enrolled in ORION: A Prospective, Multicenter Clinical Trial of the OMNI Surgical System in Pseudophakic, Mild-to-Moderate Glaucoma Patients

Trial to Provide Surgeons with Prospective, Standalone Clinical Data on Microinvasive Glaucoma Surgery MENLO PARK, Calif., Aug. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Sight Sciences, Inc., a growth-stage medical device company transformi... Devices, Ophthalmology Sight Sciences, OMNI Surgical System, microinvasive, glaucoma surgery, glaucoma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news